In the evening of January 19,2022,PIEN TZE HUANG published its performance result in 2021.It was disclosed that the annual total revenue of PIEN TZE HUANG reached 8.026 billion yuan,an increase of 23.27% yearon-year;the net profit belonging to the listed company shareholders stood at 2.433 billion yuan,up by 45.55% against the last year;the basic earnings per share was 4.03 yuan while the basic earnings per share one year before remained 2.77 yuan.According to the report,the growth of the company’s operating income was mainly due to the strengthening of market planning and the expansion of saleschannels.The holding subsidiary of Xiamen PIEN TZE HUANG Hongren Pharmaceutical Company Limited(merger)and the holding subsidiary of Fujian PIEN TZE HUANG Hongren Pharmaceutical Company Limited(merger)contributed to the rise of revenue by selling.